Sumeet Industries Q1 FY27: Revenue Up 9% to ₹272.74 Cr, Profit Impacted by Input Costs
Sumeet Industries reported Q1 FY27 revenue of ₹272.74 Cr, up 9% YoY, impacted by input cost inflation. The company raised ₹199.75 Cr via a rights issue for working capital, CP plant integration, debt repayment, and solar power. The Narkoda CP plant acquisition is expected to double capacity. FY27 revenue growth target is over 30% with 6% EBITDA margin.
The company has undertaken significant strategic initiatives including a rights issue, acquisition, and plans for capacity expansion and renewable energy. These are expected to drive future growth and improve financial performance, but the immediate impact on Q1 results was mixed.
While revenue grew, profitability was impacted by industry-wide cost inflation. The successful rights issue and strategic acquisitions/investments provide a positive outlook, but the immediate financial results show pressure.
Sumeet Industries Limited reported its Un-Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026. The company's income increased by over 9% year-on-year to ₹272.74 crore. EBITDA stood at ₹8.85 crore with a margin of 3.24%, and Profit After Tax (PAT) for the quarter was ₹1.14 crore.
The profitability was impacted by industry-wide headwinds, including a sharp increase in crude oil prices due to geopolitical tensions, leading to volatility in raw materials like PTA and MEG, and elevated freight costs. These factors created margin pressure across the polyester value chain. However, underlying demand remained encouraging across apparel, home textiles, and industrial applications.
The company successfully completed its rights issue, allotting 16.84 crore equity shares at ₹11.86 per share, raising ₹199.75 crore. Net proceeds of approximately ₹194.90 crore will be deployed towards strengthening working capital (₹100 crore), operationalizing the new acquired CP plant (₹50 crore), repayment of borrowings (₹23 crore), and investment in a captive solar power plant (₹22 crore).
The acquisition of Narkoda Limited's CP plant for ₹23.47 crore is a significant growth driver. This plant, with a capacity of 1,40,000 tons per annum of PET chips, is expected to double the company's existing capacity upon recommissioning, strengthening backward integration and improving cost competitiveness. The plant is targeted for commissioning in the second quarter of the next financial year.
Looking ahead, Sumeet Industries is optimistic about delivering more than 30% revenue growth in the current financial year '27, with an expected EBITDA margin of around 6% and PAT in the range of 3.5% to 4%. The company also expects significant reduction in finance costs due to debt repayment and aims to achieve gross margins over 25% to meet its EBITDA targets. The company also plans to commence exports and is targeting the second quarter of the next financial year for the commissioning of its renewable solar power plant, which is expected to save ₹25 crore per annum in power costs.
What to do with a filing like this
Sumeet Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sumeet Industries Limited. Read the original for the full detail.